Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.49p
   
  • Change Today:
    -0.21p
  • 52 Week High: 40.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 248,059
  • Market Cap: £28.83m
  • RiskGrade: 479
  • Beta: 0.01

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (2.93) (0.99)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.87) (1.83)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (6.87) (2.03)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.10 (6.89) (2.21)p n/a n/a n/a n/a 0.0%
31-Dec-24 13.93 1.29 0.43p 73.6 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 5.04 (3.59) (1.14)p n/a n/a n/a n/a 0.0%
31-Dec-26 5.10 (2.58) (0.75)p n/a n/a n/a n/a 0.0%
31-Dec-27 6.57 (0.69) (0.22)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 73.60 73.60 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Futura Medical Market Data

Currency UK Pounds
Share Price 9.49p
Change Today -0.21p
% Change -2.16 %
52 Week High 40.00
52 Week Low 8.00
Volume 248,059
Shares Issued 303.83m
Market Cap £28.83m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% below the market average41.52% below the market average41.52% below the market average41.52% below the market average41.52% below the market average
34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average34.78% above the sector average
Price Trend
94.21% below the market average94.21% below the market average94.21% below the market average94.21% below the market average94.21% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Income Not Available
Growth
23.02% above the market average23.02% above the market average23.02% above the market average23.02% above the market average23.02% above the market average
24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average24.14% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 04-Jun-2025

Time Volume / Share Price
16:24 50,000 @ 9.44p
16:21 21,795 @ 9.44p
15:09 100 @ 9.02p
15:09 28 @ 9.90p
15:09 11 @ 9.02p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page